genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Neurons Grown in the Lab Strikingly Similar to Brain Cells
News
Aptinyx Weighs Lead Candidate’s Development in Chronic Pain after Phase II…
News
CRISPR Aids Fight Against Neglected Tropical Diseases
News
Endocrine-Disrupting Chemical Found in Store Receipts
News
ALS Researchers Discover New Biomarker and Drug Target
Insights
Insights
Top 10 Global Biopharma IPOs of 2018
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
A-Lists
Insights
Top 10 Global Biopharma IPOs of 2018
A-Lists
5 Biopharma Trends to Watch in 2019
A-Lists
Top 10 RNA-Based Biopharmas of 2018
Insights
Top 10 Molecular Millionaires of 2018
A-Lists
Top 10 Pharma Companies of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Webinars
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
News
Neurons Grown in the Lab Strikingly Similar to Brain Cells
News
Aptinyx Weighs Lead Candidate’s Development in Chronic Pain after Phase II…
News
ALS Researchers Discover New Biomarker and Drug Target
Magazine
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
January 2019 Vol. 39 No. 1
PATH: New Organization Fostering AI, Automation and Healthcare
Resources
All
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Webinars
The Secret to Improving the Therapeutic Index of Antibody Drug Conjugates
Webinars
Streamlined Formulation of Enzyme Products
January 2019 Vol. 39 No. 1
American Association for the Advancement of Science
January 2019 Vol. 39 No. 1
Virtual Fly Brain
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Fill and Finish
Fill and Finish
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Fill and Finish
Catalent Invests $200M in Fast-Growing Biologics Manufacturing Business
Fill and Finish
Merck KGaA Plans €35M Expansion of Italian Manufacturing Site
Fill and Finish
AMRI Acquires Aptuit Businesses
Fill and Finish
Merck Targets Italian Production Site for Investment
Fill and Finish
Baxter to Invest $1B in Construction of New Plasma Products Facility in Georgia
Fill and Finish
Lpath Puts the Brakes on Two Ophthalmology Trials due to Manufacturing...
Fill and Finish
Dalton to Provide Aseptic Fill/Finish Services to AdeTherapeutics
Fill and Finish
Formatech to Donate Fill/Finish Services to Femta for One Lot of...
Fill and Finish
LBL to Supply Proliant BSA to Small-Scale Customers
Fill and Finish
AMRI Takes Over Hyaluron for $27M
Fill and Finish
Therapure Biopharma to Perform Fill/Finish of YM Biosciences’ Nimotuzumab
Fill and Finish
Formatech to Fill and Finish One Lot of KAI Pharmaceuticals’ SHPT...
Fill and Finish
Formatech to Donate Services to Formulate and Fill a GeoVax HIV...
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
![Firm will now be able to offer sterile fill and finish services for small molecules and biologics. [© Thomas Brugger - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/June15_2010_2197218_Syringes_AMRIBuysHyaluron9726351296-324x160.jpg "AMRI Takes Over Hyaluron for $27M")
